This is a serious condition that affects many parts of your body. It causes inflammation in your blood vessels, which can damage organs like your lungs and kidneys. It's often linked to specific antibodies in your blood. This condition is sometimes called Wegener's disease.
Every report comes from a Lived member, sent anonymously.
Have you tried Rituximab for Granulomatosis with Polyangiitis?
Granulomatosis with polyangiitis (GPA) is a rare autoimmune disease in which the immune system inflames small blood vessels. Inflamed vessels carry less blood to the tissues they supply, and the surrounding tissue can be damaged. GPA most often affects the nose, sinuses, ears, lungs and kidneys, though the eyes, skin, joints and nerves can be involved too. It was formerly called Wegener's granulomatosis. Early signs are often easy to mistake for a stubborn cold or sinus infection: sinus trouble that keeps returning, nosebleeds, crusting or sores inside the nose, ear infections, fever without a clear cause, night sweats, tiredness and weight loss. When the lungs are involved, people may cough, sometimes with blood, or become short of breath. Kidney involvement often causes no symptoms at first, which is why urine tests matter. GPA belongs to a group called ANCA-associated vasculitis, named for antineutrophil cytoplasmic antibodies (ANCA), immune proteins found in the blood of most people with active disease. Its close relatives, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis (which usually comes with asthma), are treated in similar but not identical ways. Untreated severe GPA can be fatal within months, but modern treatment has transformed the outlook, and most people improve substantially.
GPA is an autoimmune disease: the immune system attacks the body's own blood vessels. Why this starts in a particular person is usually unknown. Researchers think it reflects a combination of inherited susceptibility and outside triggers, but no single cause has been identified, and it is not contagious. GPA can begin at any age, although it is most common in middle-aged adults and is rare in children. Men and women are affected about equally, and it is more common in people of northern European descent. Rarely, a similar ANCA-positive vasculitis is caused by a substance, such as cocaine contaminated with levamisole (a veterinary deworming drug) or certain medicines, including hydralazine (a blood pressure medicine), propylthiouracil (a thyroid medicine) and minocycline (an antibiotic). There is no known way to prevent GPA.
No single test confirms GPA. Diagnosis rests on the pattern of symptoms together with blood tests, urine tests, imaging and, often, a biopsy. Because early symptoms resemble common infections, people sometimes see several clinicians before the diagnosis is made. The key blood test looks for ANCA, the antineutrophil cytoplasmic antibodies described above. In GPA, the antibody is usually the kind directed at a protein called proteinase 3 (PR3), sometimes reported as c-ANCA or PR3-ANCA. A positive result strongly supports the diagnosis in the right setting, but a negative result does not rule GPA out, and ANCA levels alone do not show how active the disease is. A urine test checks for blood and protein, early signs of kidney inflammation, and blood tests measure kidney function and general inflammation. A chest X-ray or CT (computed tomography) scan looks for nodules or other lung changes, and a sinus CT can show damage to the bone around the nose. A biopsy, a small sample of affected tissue such as kidney, nasal lining, lung or skin, can confirm the diagnosis and show how severe the damage is. Clinicians also test for infections and other diseases that can look similar.
Treatment has two stages. The first, called remission induction, aims to switch off the inflammation quickly and protect organs. The second, maintenance, aims to keep the disease quiet and prevent relapse, usually for about two years or more, and longer for people who have relapsed. Because GPA can affect many organs, care often involves a rheumatologist working with kidney, lung and ear, nose and throat specialists. For severe disease, meaning disease that threatens a vital organ such as the kidneys or lungs, treatment usually combines a glucocorticoid (a steroid such as prednisone, sometimes given first by IV) with a stronger immune-suppressing medicine. US guidelines prefer rituximab (Rituxan, also available as biosimilars, near-identical versions made by other companies), an antibody given by IV infusion that removes B cells, the immune cells that go on to make ANCA, over cyclophosphamide, an older chemotherapy-type drug. The two work similarly well, but cyclophosphamide carries more risk of low blood counts, bladder injury and infertility, so it is now kept for selected situations. Avacopan (Tavneos), a newer pill that blocks a signal driving the inflammation, may be added for severe disease to help lower the steroid dose; it requires regular liver blood tests. For GPA that is not organ-threatening, methotrexate, an immune-suppressing medicine taken weekly, is usually started alongside a steroid. For maintenance, rituximab given every few months is generally preferred, with methotrexate or azathioprine (another immune-suppressing pill) as alternatives. When the kidneys are severely affected, plasma exchange, a procedure that filters the blood, may be considered for people at high risk of kidney failure; it can lower that risk but adds infection risk and is not used routinely. The main trade-off of all these treatments is a weakened defense against infection. Doctors usually prescribe a preventive antibiotic, typically trimethoprim-sulfamethoxazole (Bactrim), against a serious lung infection called Pneumocystis pneumonia, check for hepatitis B before rituximab, because it can reawaken a dormant hepatitis B infection, and review vaccinations. Steroid doses are tapered as quickly as is safe, because long-term steroids can cause bone loss, weight gain, high blood sugar and other problems.
With treatment, most people reach remission, meaning no signs of active inflammation, although recovery of energy can lag behind. Damage that happened before the disease was controlled may not fully reverse. Kidney function sometimes stays reduced, hearing loss is common and can be subtle, and destruction of cartilage in the nose can leave a hole in the wall between the nostrils or a flattened bridge of the nose (saddle nose). Some people develop narrowing of the airway just below the vocal cords, which can cause hoarseness or noisy breathing and may need treatment from an ear, nose and throat specialist. GPA is best thought of as a long-term condition. Relapses are common, particularly when treatment is reduced or stopped, and some people need several courses of treatment over the years. Regular visits with blood and urine tests track kidney function, medicine side effects and early signs of a flare, sometimes before symptoms appear. Decisions about when to stop maintenance treatment are made individually. People with GPA also have a higher risk of blood clots in the legs and lungs. If you could become pregnant, plan ahead with your care team, because some GPA medicines can harm a developing baby and need changing beforehand. Men planning to father a child should ask too, since the advice differs and cyclophosphamide can affect fertility in both sexes. If the kidneys fail, dialysis is needed, and people whose disease is in remission can be evaluated for a kidney transplant, with results similar to transplants for other reasons. Patient organizations such as the Vasculitis Foundation offer information and peer support.
See a clinician if sinus problems, nosebleeds, nasal crusting or ear infections keep returning despite usual treatment, especially alongside fever, night sweats, weight loss or joint pain. If you already have GPA, contact your care team soon, rather than waiting for your next scheduled visit, if old symptoms return or you notice new hoarseness, noisy breathing or hearing changes, because a relapse treated early is easier to control. Contact your care team promptly if you notice blood in your urine, a new cough, chest pain or shortness of breath, a painful red eye or change in vision, new numbness or weakness in a hand or foot, or a fever or other signs of infection while on immune-suppressing treatment. Seek emergency care if you cough up more than streaks of blood or are struggling to breathe, because bleeding into the lungs is a dangerous complication of GPA that needs treatment in hospital.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Granulomatosis with Polyangiitis is like, what's helped you, or ask the community a question.